Seo et al., 2020 - Google Patents
A mixed micellar formulation for the transdermal delivery of an indirubin analogSeo et al., 2020
View HTML- Document ID
- 16519205563987414176
- Author
- Seo S
- Kim E
- Joo Y
- Lee J
- Oh K
- Hwang S
- Choi K
- Publication year
- Publication venue
- Pharmaceutics
External Links
Snippet
Indirubin is an active component of Dang Gui Long Hui Wan, which has been used in traditional Chinese medicine to treat inflammatory diseases as well as for the prevention and treatment of human cancer, such as chronic myeloid leukemia. The therapeutic effects of …
- 239000000203 mixture 0 title abstract description 103
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
- A61K47/08—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycol [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Seo et al. | A mixed micellar formulation for the transdermal delivery of an indirubin analog | |
Ha et al. | Preparation and evaluation of resveratrol-loaded composite nanoparticles using a supercritical fluid technology for enhanced oral and skin delivery | |
Murthy et al. | Oral bioavailability enhancement of raloxifene with nanostructured lipid carriers | |
Usach et al. | Magnolol and honokiol: two natural compounds with similar chemical structure but different physicochemical and stability properties | |
Tofani et al. | Formulation, characterisation, and in vitro skin diffusion of nanostructured lipid carriers for deoxyarbutin compared to a nanoemulsion and conventional cream | |
Nagaraja et al. | Topical nanoemulgel for the treatment of skin cancer: Proof-of-technology | |
Mehenni et al. | Preparation and characterization of spherical amorphous solid dispersion with amphotericin B | |
Nagai et al. | Involvement of endocytosis in the transdermal penetration mechanism of ketoprofen nanoparticles | |
Zhang et al. | Development of an oral compound pickering emulsion composed of nanocrystals of poorly soluble ingredient and volatile oils from traditional Chinese medicine | |
Lee et al. | Development and evaluation of raloxifene-hydrochloride-loaded supersaturatable SMEDDS containing an acidifier | |
Li et al. | Hydroxypropyl-β-cyclodextrin for delivery of baicalin via inclusion complexation by supercritical fluid encapsulation | |
Bi et al. | Improved oral bioavailability using a solid self-microemulsifying drug delivery system containing a multicomponent mixture extracted from Salvia miltiorrhiza | |
Siddiqui et al. | Investigation of a minocycline-loaded nanoemulgel for the treatment of acne rosacea | |
Zaki et al. | Formulation and evaluation of transdermal gel containing tacrolimus-loaded spanlastics: in vitro, ex vivo and in vivo studies | |
Shakeel et al. | Nanoemulsification improves the pharmaceutical properties and bioactivities of niaouli essential oil (Melaleuca quinquenervia L.) | |
Abushal et al. | Self-nanoemulsifying drug delivery system (SNEDDS) of apremilast: In vitro evaluation and pharmacokinetics studies | |
Wang et al. | Development and evaluation of docetaxel-phospholipid complex loaded self-microemulsifying drug delivery system: optimization and in vitro/ex vivo studies | |
Sharif Makhmal Zadeh et al. | Permeability of ciprofloxacin-loaded polymeric micelles including ginsenoside as P-glycoprotein inhibitor through a Caco-2 cells monolayer as an intestinal absorption model | |
Takayama et al. | Characterization of nanoparticles using DSPE-PEG2000 and soluplus | |
Park et al. | Development of alectinib-suspended SNEDDS for enhanced solubility and dissolution | |
Khan et al. | Lornoxicam-loaded chitosan-decorated nanoemulsion: preparation and in vitro evaluation for enhanced transdermal delivery | |
He et al. | Molecular dynamics simulation of drug solubilization behavior in surfactant and cosolvent injections | |
Banshoya et al. | Coenzyme Q10-polyethylene glycol monostearate nanoparticles: an injectable water-soluble formulation | |
Zheng et al. | Microemulsion delivery system improves cellular uptake of genipin and its protective effect against Aβ1-42-induced PC12 cell cytotoxicity | |
Rahman et al. | Intravenous nanocarrier for improved efficacy of quercetin and curcumin against breast cancer cells: development and comparison of single and dual drug–loaded formulations using hemolysis, cytotoxicity and cellular uptake studies |